This Activity Requires You To Leave myCME.

You are now leaving myCME and connecting to our educational partner. myCME does not control content, practices, or other policies of the site you are entering.

You are about to open a webpage that is outside of this educational content.

  • Overview
  • Activity
    • Ivermectin (Sklice..
    • Ezogabine (Potiga)
    • Mifepristone (Korl..
    • Emtricitabine/Teno..
    • Phentermine Hydroc..
    • Tafluprost Ophthal..
    • Peginesatide (Omon..
    • Indacaterol Inhala..
  • Post-Test
  • Evaluation
  • Claim Credit
This CME Activity has expired and is no longer available for credit.
New Drug Review from MPR (September 2012)

New Drug Review from MPR (September 2012)

Format

Knowledge

Time to Complete

1 hour

Released

September 20, 2012

Expires

September 20, 2013

Maximum Credits

1.00 / AMA PRA Category 1 Credit(s)TM

Accredited Provider

Jointly sponsored by Postgraduate Institute for Medicine and Haymarket Medical Education
If you have any questions relating to the accreditation of this activity, please contact information@pimed.com.

Commercial Supporter

There is no commercial support for this activity.

Program Description

Clinicians should be informed and stay current about new molecular entities and new indications of drugs for use in everyday practice. This CME/CEU activity is designed to give clinicians a better understanding of the pharmacology, indications, contraindications, benefits/risk, and clinical trials data of a broad spectrum of new agents and those that have been granted a new indication. This activity will allow these health care professionals to make the most up-to-date—and most appropriate—therapeutic decisions for their patients.

Educational Objectives

After participating in this activity, clinicians should be better able to:

  • List drug names, mechanisms of action, and pharmacologic properties
  • Identify contraindications and precautions that may preclude or condition the drug’s use
  • Outline potential adverse drug reactions, drug interactions, and necessary monitoring parameters
  • Discuss route of administration, dosing schedule, and dosing formulations
  • Compare therapy with other members of the same therapeutic class
  • For Pharmacists Only: Provide accurate and appropriate counsel as part of the treatment team

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) assesses conflicts of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

Faculty

Evelyn Hermes-DeSantis, PharmD
Clinical Associate Professor
Ernest Mario School of Pharmacy at Rutgers,
The State University of New Jersey
Director, Drug Information Services
Robert Wood Johnson University Hospital
New Brunswick, NJ

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Evelyn Hermes-DeSantis, PharmD, has nothing to disclose.

Publishing Staff Disclosure

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following Haymarket Medical Education planners over the past 12 months: Nick Zittell, Editor; Kathryn Kovalycsik, PharmD, writer; and Lynne Callea, Program Director, have nothing to disclose.

The following PIM planners and managers over the past 12 months: Laura Excell, ND, NP, MS, MA, LPC, NCC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CCMEP; Jan Schultz, RN, MSN, CCMEP; and Patricia Staples, MSN, NP-C, CCRN, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Type of Activity

Knowledge

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and Haymarket Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CE for Pharmacists

Accreditation Statement

Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Designation Statement

Postgraduate Institute for Medicine designates this continuing education activity for 1.00 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number (UAN) 0809-9999-12-355-H01-P.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM) and Haymarket Medical Education do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM or Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

To obtain credit, a score of 70% or better is required. This CME is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Click the "Start Activity" button to indicate you have reviewed the CME/CE information for this activity.
Add to Queue